moderna vaccine

Moderna’s clinical trial testing coronavirus vaccines in children ages 6-11 has entered its final phase. With the possibility of a second vaccine available this fall for kids under 12, News4’s Doreen Gentzler reports.

With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they’re confident there will be enough for every American who qualifies

U.S. health officials say that the Moderna booster shot will need more time to be reviewed which will likely delay President Biden’s plan to offer COVID-19 booster shots to all Americans in mid-September.

A preliminary survey out of Israel suggests that a coronavirus booster shot may cause similar side effects to the second dose.

The U.S. government’s top infectious disease expert, Dr. Anthony Fauci, says he’s hopeful that the Food and Drug Administration will give full approval to the coronavirus vaccine by month’s end.

Moderna said Monday that it is “actively discussing a proposal with the FDA” to expand its coronavirus vaccine trial to include children ages 5 to 11. The company hopes to expand its trial to include children in this age group by the end of the year.

So far, the “variant of interest” has been detected in 29 countries, and it may spread more quickly than milder versions of the coronavirus.

A new study from the University of Miami found that the Pfizer and Moderna coronavirus vaccines– the two mRNA vaccines that currently have emergency use authorization in the U.S.– do not contribute to male infertility.

Moderna filed a request with the FDA to authorize its COVID-19 vaccine for use in adolescents ages 12 to 17.

Moderna filed on Tuesday to request full FDA approval of its coronavirus vaccine, which was granted emergency use authorization in December.

Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12.

A new report from Yale University noted that several people developed a raised, itchy patch of skin at the injection site a few days after receiving a shot, but it was temporary and easily treated in all cases.

Children in the trial receive varying levels of the vaccine in two doses 28 days apart. Parents keep a digital diary of their child’s symptoms. News4’s Doreen Gentzler reports.

Moderna reported on Thursday that early data shows high effectiveness in its coronavirus vaccine trial in adolescents ages 12 to 17.

Moderna released findings on Tuesday from its phase three trial which showed that its coronavirus vaccine is 90% effective at preventing infections and more than 95% effective against severe disease up to six months after the second dose.

After the Johnson & Johnson vaccine was paused on Tuesday over reports of six cases of blood clotting, Jeff Zients, coordinator for the White House coronavirus response, and Dr. Anthony Fauci, NIAID director, spoke to reporters on the impact the pause will have on the coronavirus vaccine initiative.

As more Americans get fully vaccinated against the coronavirus, the number of breakthrough infections is expected to rise, too. Here’s what you need to know about this medical phenomenon.

The United States reached a milestone in its efforts to combat the coronavirus, with one in four American adults now fully vaccinated.

The Moderna vaccine offers protection against COVID-19 for at least six months, according to a report in the New England Journal of Medicine.